Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Susanne K. Kjær"'
Autor:
Christian Munk, Christian Dehlendorff, Mari Nygård, Susanne K. Kjaer, Suzanne Campbell, Anne O. Olsen, Madleen Orumaa, Bo T. Hansen
Publikováno v:
Orumaa, M, Kjaer, S K, Dehlendorff, C, Munk, C, Olsen, A O, Hansen, B T, Campbell, S & Nygård, M 2020, ' The impact of HPV multi-cohort vaccination : Real-world evidence of faster control of HPV-related morbidity ', Vaccine, vol. 38, no. 6, pp. 1345-1351 . https://doi.org/10.1016/j.vaccine.2019.12.016
Background: In 2009, both Norway and Denmark initiated routine quadrivalent human papillomavirus vaccination (qHPV) for 12-year-old girls; however, Denmark also introduced free-of-charge multi-cohort vaccination for older age groups in 2008. We aim t
Autor:
Mari Nygård, Bo T. Hansen, Kai Li Liaw, Joakim Dillner, Maria Hortlund, Christian Munk, Susanne K. Kjaer, Camilla Lagheden
Publikováno v:
Vaccine. 36:3820-3829
To monitor the changes in prevalence of human papillomavirus (HPV) infections in women50 years of age, participating in cervical screening programs of Denmark, Norway, and Sweden, before and after introduction of quadrivalent HPV (qHPV) vaccination.L
Autor:
Joakim Dillner, Mari Nygård, Christian Munk, Maria Hortlund, Bo T. Hansen, Camilla Lagheden, Kai-Li Liaw, Susanne K. Kjaer
Publikováno v:
Vaccine. 38:5741
Autor:
Christian Dehlendorff, Susanne K. Kjaer, Christian Munk, Anne Katrine Duun-Henriksen, Manrinder Kaur Tatla, Mette Tuxen Faber
Publikováno v:
Vaccine. 37(2)
Background Few studies have studied the association between unintended human papillomavirus (HPV) vaccination and adverse pregnancy outcomes. This study set out to determine the association between HPV vaccination during pregnancy and subsequent risk
Autor:
Eva Herweijer, Ingrid Uhnoo, Pär Sparén, Alexander Ploner, Christian Dehlendorff, Birgitte Baldur-Felskov, Lisen Arnheim-Dahlström, Susanne K. Kjaer
Publikováno v:
Vaccine. 36(43)
Background Based on immunogenicity studies, a 2 dose HPV vaccination-schedule was recently recommended for girls younger than 15 years. We aimed to investigate the effectiveness of quadrivalent HPV (qHPV) vaccination against CIN2 or worse (CIN2+), by
Autor:
Steve Schwartz, Christina Jensen, Charles J.N. Lacey, Henry C Kitchener, Ian N. Hampson, Johannes Berkhof, Isabelle Heard, Lawrence Banks, Ginesa Albero, Connie Trimble, Myriam Chevarie-Davis, Wim Quint, Thomas R. Broker, Christine Bergeron, Xavier Castellsagué, Maria Brotons, Pierre Van Damme, Martyn Plummer, Laia Alemany, D. Scott LaMontagne, Jane J. Kim, Joel M. Palefsky, Vivien Tsu, F. Xavier Bosch, Jack Cuzick, Anna R. Giuliano, George Koliopoulos, Jose Jeronimo, Rengaswamy Sankaranarayanan, Freddie Bray, Heather Cubie, Marc T. Goodman, William A. Fisher, Mark Schiffman, Karen Canfell, Mireia Diaz, Catherine de Martel, Silvia de Sanjosé, Gina Ogilvie, Peter J.F. Snijders, Philip E. Castle, Julian Peto, Anil K. Chaturvedi, Scott Wittet, Chris J.L.M. Meijer, Lynette Denny, Jerome L. Belinson, Boŝtjan J. Kocjan, Beatriz Serrano, John T. Schiller, Ann N. Burchell, Anne Szarewski, Eduardo Lazcano-Ponce, Shelley L. Deeks, Walter Kinney, David Forman, Ligia A. Pinto, Joannie Lortet-Tieulent, Guglielmo Ronco, Joakim Dillner, Thomas Iftner, Bettie M. Steinberg, Marc Steben, Susanne K. Kjaer, Anna-Barbara Moscicki, Patti E. Gravitt, Attila T. Lorincz, Marc Arbyn, Peter L. Stern, Mario Poljak, Ahti Anttila, John Doorbar, Isabelle Soerjomataram, Ignacio G. Bravo, Eduardo L. Franco, Jacques Ferlay, Magnus von Knebel Doeberitz, You-Lin Qiao, Alex Vorsters, Pontus Naucler, Silvia Franceschi, Alison Nina Fiander, Andrea Vicari, Maura L. Gillison, Harrell W. Chesson, Suzanne M. Garland, Laia Bruni, Sjoerd H. van der Burg, Susan A. Wang, Shalini L Kulasingam, Sandra D. Isidean, Mark A. Kane, Jérôme Vignat, Mark H. Einstein, Julia M.L. Brotherton, Jennifer S. Smith, Mark H. Stoler, Margaret Stanley, Lauri E. Markowitz
Publikováno v:
Vaccine; Vol 31
Vaccine
Bosch, F X, Broker, TR, Forman, D, Moscicki, A B, Gillison, M L, Doorbar, J, Stern, P L, Stanley, M, Arbyn, M, Poljak, M, Cuzick, J, Castle, P E, Schiller, J T, Markowitz, L E, Fisher, W A, Canfell, K, Denny, L A, Franco, E L, Steben, M, Kane, M A, Schiffman, M, Meijer, C J L M, Sankaranarayanan, R, Castellsague, X, Kim, J J, Brotons, M, Alemany, L, Albero, G, Diaz, M & de Sanjose, S 2013, ' Comprehensive control of human papillomavirus infections and related diseases ', Vaccine, vol. 31, no. Suppl 7, pp. H1-H31 . https://doi.org/10.1016/j.vaccine.2013.07.026
Vaccine, vol 31 Suppl 7, iss Suppl 7
Vaccine, vol 31 Suppl 8, iss 0 8
Vaccine, 31(Suppl 7), H1-H31. Elsevier BV
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Vaccine
Bosch, F X, Broker, TR, Forman, D, Moscicki, A B, Gillison, M L, Doorbar, J, Stern, P L, Stanley, M, Arbyn, M, Poljak, M, Cuzick, J, Castle, P E, Schiller, J T, Markowitz, L E, Fisher, W A, Canfell, K, Denny, L A, Franco, E L, Steben, M, Kane, M A, Schiffman, M, Meijer, C J L M, Sankaranarayanan, R, Castellsague, X, Kim, J J, Brotons, M, Alemany, L, Albero, G, Diaz, M & de Sanjose, S 2013, ' Comprehensive control of human papillomavirus infections and related diseases ', Vaccine, vol. 31, no. Suppl 7, pp. H1-H31 . https://doi.org/10.1016/j.vaccine.2013.07.026
Vaccine, vol 31 Suppl 7, iss Suppl 7
Vaccine, vol 31 Suppl 8, iss 0 8
Vaccine, 31(Suppl 7), H1-H31. Elsevier BV
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Infection with human papillomavirus (HPV) is recognized as one of the major causes of infection-related cancer worldwide, as well as the causal factor in other diseases. Strong evidence for a causal etiology with HPV has been stated by the Internatio
Autor:
Margaret Stanley, Thomas Verstraeten, Karl Ulrich Petry, Susanne K. Kjaer, Pierre Van Damme, Benoît Soubeyrand, F. Xavier Bosch, Elmar A. Joura, Paolo Bonanni, Chris J.L.M. Meijer
Publikováno v:
Vaccine. 34(39):4759-4760
Autor:
Keith S. Reisinger, Nina B Latham, Catherine Cohet, Paul-Henri Lambert, Richard M. Haupt, Paolo Bonanni, Susanne K. Kjaer
Publikováno v:
Vaccine. 28:4719-4730
GARDASIL has been shown to reduce the incidence of pre-cancerous cervical, vulvar, and vaginal lesions, and external genital warts causally related to HPV6/11/16/18. Because of its expected public health benefit on reduction of cervical cancer and ot
Autor:
Nubia Muñoz, Mark Schiffman, Guillermo Tortolero-Luna, Laia Bruni, F. Xavier Bosch, Anna R. Giuliano, Silvia de Sanjosé, Susanne K. Kjaer, Ann N. Burchell
Publikováno v:
Vaccine. 26:K1-K16
Worldwide human papillomavirus (HPV) prevalence in women with normal cytology at any given point in time is approximately 10% indicating that HPV is one of the most common sexually transmitted infections. HPV-16 is consistently the most common type a
Autor:
Eileen F. Dunne, Linda O. Eckert, Olga G. Martinez-Montañez, Roberta I. Howlett, Lauri E. Markowitz, Charlene A. Wong, Katy Sinka, Susanne K. Kjaer, Mona Saraiya, Julia M.L. Brotherton, Susan Hariri
Publikováno v:
Vaccine. 29(5)
In this review, we describe plans to monitor the impact of human papillomavirus (HPV) vaccine on biologic outcomes in selected international areas (Australia, Canada, Mexico, the Nordic countries, Scotland, and the United States) that have adopted th